Unknown

Dataset Information

0

Structure-based design of novel human Toll-like receptor 8 agonists.


ABSTRACT: Toll-like receptor (TLR)-8 agonists activate adaptive immune responses by inducing robust production of T helper 1-polarizing cytokines, suggesting that TLR8-active compounds might be promising candidate vaccine adjuvants. Recently, a C2-butyl furo[2,3-c]quinoline was reported with purely TLR8 agonistic activity. This compound was successfully co-crystallized with the human TLR8 ectodomain, and the co-crystal structure revealed ligand-induced reorganization of the binding pocket of TLR8. The loss of a key hydrogen bond between the oxygen atom of the furanyl ring of the agonist and Thr 574 in TLR8 suggested that the furan ring is dispensable. Employing a disconnection strategy, 3- and 4-substituted aminoquinolines were investigated. Focused structure-based ligand design studies led to the identification of 3-pentyl-quinoline-2-amine as a novel, structurally simple, and highly potent human TLR8-specific agonist (EC50 =0.2 ?M). Preliminary evaluation of this compound in ex vivo human blood assay systems revealed that it retains prominent cytokine-inducing activity. Together, these results indicate the suitability of this compound as a novel vaccine adjuvant, warranting further investigation.

SUBMITTER: Kokatla HP 

PROVIDER: S-EPMC4105021 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-based design of novel human Toll-like receptor 8 agonists.

Kokatla Hari Prasad HP   Sil Diptesh D   Tanji Hiromi H   Ohto Umeharu U   Malladi Subbalakshmi S SS   Fox Lauren M LM   Shimizu Toshiyoki T   David Sunil A SA  

ChemMedChem 20140128 4


Toll-like receptor (TLR)-8 agonists activate adaptive immune responses by inducing robust production of T helper 1-polarizing cytokines, suggesting that TLR8-active compounds might be promising candidate vaccine adjuvants. Recently, a C2-butyl furo[2,3-c]quinoline was reported with purely TLR8 agonistic activity. This compound was successfully co-crystallized with the human TLR8 ectodomain, and the co-crystal structure revealed ligand-induced reorganization of the binding pocket of TLR8. The los  ...[more]

Similar Datasets

| S-EPMC5836741 | biostudies-literature
| S-EPMC4601487 | biostudies-literature
| S-EPMC4027615 | biostudies-literature
| S-EPMC7553670 | biostudies-literature
| S-EPMC2911294 | biostudies-literature
| S-EPMC3228886 | biostudies-literature
| S-EPMC6561087 | biostudies-literature
| S-EPMC6256730 | biostudies-literature
| S-EPMC10760790 | biostudies-literature
| S-EPMC6017214 | biostudies-literature